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 18 
Autophagy is an intracellular clearance pathway that delivers cytoplasmic contents to 19 
the lysosome for degradation. It plays a critical role in maintaining protein homeostasis 20 
and providing nutrients under conditions where the cell is starved.  It also helps to 21 
remove damaged organelles and misfolded or aggregated proteins.  Thus, it is not 22 
surprising that defects in this pathway are associated with a variety of pathological 23 
conditions, such as neurodegeneration, cancer and infection. Pharmacological 24 
upregulation of autophagy is considered a promising therapeutic strategy for the 25 
treatment of neurodegenerative and infectious diseases. Studies in knockout mice 26 
have demonstrated that autophagy is essential for nervous system function and data 27 
from invertebrate and vertebrate models suggest that the efficiency of autophagic 28 
processes generally declines with age. However, much of our understanding of the 29 
intracellular regulation of autophagy comes from in vitro studies and there is a paucity 30 
of knowledge about how this process is regulated within different tissues and during 31 
the processes of aging and disease.  Here, we review the available tools to probe these 32 
questions in vivo within vertebrate model systems.  We discuss how these tools have 33 
been used to date and consider future avenues of research. 34 
 35 
Autophagy cell biology 36 
In the initial steps of autophagy, a double-membraned cup-shaped precursor (called the 37 
phagophore) forms within the cytoplasm.  The phagophore expands, engulfing substrates as 38 
it does so and eventually the edges fuse to form a double-membraned vesicle, the 39 
autophagosome. This traffics along microtubules to the lysosome, with which it fuses resulting 40 
in the degradation of the autophagic contents (Fig. 1). Autophagy is controlled through a 41 
conserved family of approximately thirty core genes that encode the autophagic machinery, 42 
termed the AuTophaGy-related (atg) gene family (Feng et al., 2014).  The atg genes were 43 
originally discovered in yeast; mutations in these genes resulted in an inability to survive 44 
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nutrient deprivation conditions. Most of these genes have vertebrate homologs that are named 45 
after their yeast counterparts.  Interestingly, many of the yeast genes have more than one 46 
vertebrate homolog (Feng et al., 2014; Mizushima et al., 2011), which may contribute to either 47 
redundancy or to additional functional diversity. 48 
 49 
To follow this process in vivo, it is necessary to label and visualise the phagophores and 50 
autophagosomes.  However, few proteins are uniquely associated with autophagic vesicles 51 
and their precursors, with only one protein (LC3-II) known to label autophagic structures both 52 
prior to and after fusion with the lysosome.  LC3 is one of several vertebrate homologues of 53 
ATG8. Mammalian cells have six ATG8 orthologues; the MAP1-LC3 (LC3) and GABARAP 54 
subfamilies (microtubule-associated protein 1 light chain 3 and GABA(A) receptor-associated 55 
protein families respectively), while zebrafish have eight (see Table 1). During 56 
autophagosome formation, these ATG8-family proteins are conjugated to the lipid 57 
phosphatidylethanolamine (PE) in autophagosomal membranes. This lipidation requires a 58 
protease and two ubiquitin-like conjugation systems (Ichimura et al., 2000; Mizushima et al., 59 
1998)(Fig 1). ATG4 is a cysteine protease that cleaves the C-terminus of LC3 exposing a 60 
glycine residue.  This first cleaved form of LC3 is called LC3-I. A further reaction then occurs 61 
involving a complex of ATG proteins that act as an E3-like ligase. This determines the site of 62 
LC3 lipidation and assists the transfer of LC3-I to PE to form LC3-II (Ichimura et al., 2000).  63 
 64 
Since lipidated ATG8 proteins (such as LC3-II) are the only proteins which associate with pre-65 
autophagosomal structures, autophagosomes and autolysosomes, they are widely accepted 66 
as being the best marker to distinguish autophagic vesicles from other cellular membranes 67 
(Klionsky et al., 2016; Mizushima et al., 2010). Measuring LC3 lipidation by western blotting, 68 
counting the number of LC3 vesicles by immunofluorescence or with fluorescently tagged LC3 69 
expression constructs, and detecting the degradation of long-lived proteins or damaged 70 
organelles are the most commonly used methods for monitoring autophagy (Klionsky et al., 71 
2016; Mizushima et al., 2010). However, care must be taken in interpreting increases in LC3 72 
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levels as this may occur as a result of an increase in autophagosome formation (upregulation) 73 
or a blockage in clearance.  In the latter scenario, autophagosomes are not degraded typically 74 
due to failure to fuse with lysosomes or due to an increase in lysosomal pH, which thereby 75 
inactivates the degradative enzymes (see Fig 2).   76 
 77 
The majority of studies using these biochemical or fluorescent detection methods have only 78 
provided a snapshot of autophagic activity within a single tissue at a single time.  Many studies 79 
have reported that basal levels of autophagy differ between different tissues, and we do not 80 
fully understand how these different rates are affected by pharmacological upregulation or 81 
disease pathology.  Since upregulation of autophagy is considered to be a promising 82 
therapeutic strategy for the treatment of a range of disorders including neurodegeneration, 83 
infectious disease and cancer (Galluzzi et al., 2015; Rubinsztein et al., 2015), it is vital that we 84 
understand how potential therapies act in different tissues and this can only be done by in vivo 85 
analysis.  Similarly, to understand the role of autophagy in the pathogenesis of disease, it is 86 
important to study this process in the whole animal to investigate tissue-specific changes in 87 
flux, the difference in flux between young and old animals and cell autonomous versus non-88 
cell autonomous effects.  In recent years, various transgenic reporters have been developed 89 
which may be useful to improve our understanding of autophagy in vivo.  Together with 90 
advances in imaging such as CLEM (correlated light and electron microscopy) and lightsheet 91 
microscopy, we now have the tools to interrogate this process in living vertebrate animals.  92 
Although such imaging is in its infancy, here we review the available tools and highlight the 93 
future possibilities for studying autophagy in vivo. 94 
 95 
Single fluorophore probes 96 
The use of a fusion construct comprising green fluorescent protein (GFP) tagged to LC3 was 97 
the first approach to examine autophagy in vivo in vertebrates and provided novel insights 98 
about its regulation in both physiological and pathological conditions. The overexpression of 99 
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Atg8 homologs fused with GFP had been previously described in other species, such as yeast, 100 
Caenorhabditis elegans, Dictyostelium discoideum, Drosophila melanogaster and Arabidopsis 101 
thaliana (Melendez et al., 2003; Otto et al., 2003; Rusten et al., 2004; Yoshimoto et al., 2004). 102 
GFP-LC3, like endogenous LC3, becomes conjugated to the phagophore and remains on the 103 
membrane after the complete closure of the autophagosome. Autophagosomes labelled with 104 
GFP-LC3 are evident as puncta or ring-like structures by fluorescence microscopy (Kabeya et 105 
al., 2000; Mizushima et al., 2003; Mizushima et al., 2001). GFP-LC3 can also be found on the 106 
membrane of autolysosomes but to a lesser extent. The fluorescent signal of these 107 
autolysosomes is weaker and therefore distinguishable from bright autophagosomes (Kabeya 108 
et al., 2000). 109 
The generation of transgenic mice expressing GFP-LC3 under the control of a ubiquitous 110 
promoter has allowed the post-mortem examination of GFP-LC3 localization by high-111 
resolution microscopy and in almost all tissues (Mizushima et al., 2004). The overexpression 112 
of GFP-LC3 in mice permits not only qualitative but quantitative analysis of the 113 
autophagosome numbers and does not affect endogenous autophagy, since the endogenous 114 
ratio of LC3II/LC3-I is maintained. Post-mortem analysis of tissues from this transgenic mouse 115 
have been used to measure autophagosome numbers during development (Kuma et al., 116 
2004), under starvation conditions (Mizushima et al., 2004), or in different disease states such 117 
as amyotrophic lateral sclerosis (ALS) (Tian et al., 2011), polycystic kidney disease (Tanaka 118 
et al., 2016) and cerebral ischaemia (Tian et al., 2010). In addition, primary cultures from these 119 
mice have been used for ex vivo real-time observations of GFP-LC3 positive autophagic 120 
structures (Mizushima, 2009; Mizushima et al., 2004).  121 
An important consideration in the analysis of such reporter lines is to determine whether the 122 
fluorescent protein is a faithful reporter of the endogenous protein.  Mishuzima and colleagues 123 
demonstrated by western blot analysis, that the levels of endogenous LC3 and GFP-LC3 124 
protein are organ-dependent rather than uniform. In the brain, the level of expression of GFP-125 
LC3 was comparable to endogenous LC3 whereas in other tissues GFP-LC3 was 126 
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overexpressed. Importantly, the integration of the GFP‑LC3 transgene, upstream of an open 127 
reading frame in a pseudogene in the distal region of chromosome 2, did not cause any  128 
phenotypic or genetic abnormalities in homozygous mice (Kuma et al., 2007).  129 
 130 
Zebrafish are potentially a more tractable model to study autophagy in vivo since they are 131 
amenable to a most forms of fluorescent imaging due to their size and transparency. 132 
Furthermore, analysis is not restricted to embryonic stages, as their rapid development permits 133 
the analysis of functioning organs in larvae at free-swimming stages.  Zebrafish have eight 134 
homologs of Atg8 (see Table 1) with high sequence similarity to their mammalian orthologues. 135 
He et al. generated the first transgenic zebrafish autophagy reporter lines for expressing GFP-136 
LC3 and GFP-Gabarap under the control of the constitutive cytomegalovirus (CMV) promoter 137 
(He et al., 2009). Both transgenes showed similar expression patterns; expression being 138 
especially high in spinal cord, muscle and lens. Similar to mammalian LC3, zebrafish LC3-I 139 
conjugates to phosphatidylethanolamine to generate LC3-II.  Initial studies reported that LC3-140 
II was only observed in embryos from 24 hours post-fertilization (h.p.f.) onwards by western 141 
blotting (He et al., 2009). However Lee et al. detected autophagy at approximately 15 h.p.f., 142 
evidenced by the presence autophagosomes visualized as GFP-LC3 puncta in the CMV:GFP-143 
LC3 transgenic reporter line (Lee et al., 2014). The benefit of this model is not only the ability 144 
to perform live imaging, but also to examine multiple tissues within the same animal.  Imaging 145 
of GFP-LC3 transgenic embryos by confocal fluorescence microscopy showed that the GFP-146 
LC3 protein forms few puncta in basal conditions but the number of puncta increase after 147 
autophagy upregulation by addition of rapamycin or calpain inhibitors to the embryo medium 148 
(He et al., 2009). The fusion of autophagosomes to the lysosomes can also be detected in 149 
vivo by adding Lysotracker to the embryo medium (He et al., 2009). A dramatic increase in 150 
the co-localization of LysoTracker red-labelled lysosomes with GFP-LC3 puncta was observed 151 
upon the treatment with lysosomal protease inhibitors like pepstatin A or E64d, suggesting 152 
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that basal autophagic flux is high in these embryonic and early larval stages (2 and 3 d.p.f) 153 
(Mathai et al., 2017).   154 
Several studies have exploited the ability to perform in vivo imaging in this GFP-LC3 zebrafish 155 
line, for example to study the role of autophagy in blastema formation and regeneration 156 
following fin amputation (Varga et al., 2014), or in the liver to examine autophagic responses 157 
to pharmacological manipulation (Cui et al., 2012).  The ability to perform transient gene 158 
knockdown using morpholino oligonucleotides (Bedell et al., 2011) in zebrafish has enabled 159 
the rapid analysis of candidate genes in the regulation of different stages of the autophagy 160 
pathway.  For example, transient silencing of Hs1bp3, a phosphoinositide-binding PX domain 161 
containing protein, increased the number of GFP-LC3 puncta visualized directly along the 162 
trunk of morphants compared to control embryos and this increase was greater after 163 
chloroquine treatment, suggesting increased autophagic flux in vivo (Holland et al., 2016).  A 164 
similar approach was taken to study spns1, a putative lysosomal H+-carbohydrate transporter 165 
involved in senescence and in the late stages of the autophagy/lysosome pathway. Morpholino 166 
knockdown of spns1 resulted in an accumulation of GFP puncta visualised by confocal 167 
microscopy in live embryos and was also observed in spns1 mutants (Sasaki et al., 2014). 168 
Careful characterisation using lysotracker and mCherry-LC3 transgenic fish demonstrated this 169 
was due to a block in autophagosome degradation rather than an increase in autophagosome 170 
formation.  A dual GFP-LC3;mCherry-Lamp1 reporter line recently developed by the same 171 
group was used to further elucidate the role of lysosome acidification in senescence (Sasaki 172 
et al., 2017). Although analysis was performed in vivo in in these examples, these studies 173 
relied on analysis of single timepoint images to assess autophagosome number and did not 174 
exploit the full potential of studying these events in the living organism.   175 
One example of the power of using zebrafish for in vivo observations has been in the study of 176 
the innate immune response (Varga et al., 2014). Transgenic reporters have been used to 177 
track individual immune cells throughout the whole organism in response to tissue injury or 178 
infection and to study features of swarming and resolution of inflammation (Renshaw and 179 
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Trede, 2012). The combination of in vivo light microscopy and ex vivo electron microscopy 180 
imaging opens new directions for studying the role of autophagy in infectious diseases.  181 
Transgenic GFP-LC3 zebrafish infected with Shigella have been used to investigate to study 182 
the process of bacterial clearance in vivo. Engulfed bacteria were observed to be sequestered 183 
in GFP-positive autophagosomes (Mostowy et al., 2013), a finding confirmed by post-mortem 184 
transmission electron microscopy analysis. Similarly, during Mycobacterium 185 
marinum infection in zebrafish, the bacteria were frequently found associated with GFP-LC3-186 
positive vesicles, and these associations were particularly abundant in leukocytes. By 187 
correlative light and electron microscopy, the precise location of intracellular bacteria could be 188 
elucidated (either free, in autophagosomes or associated to lysosomes) by determining the 189 
ultrastructure of GFP-LC3-positive structures (Hosseini et al., 2014).  190 
These studies highlight the importance of verifying the properties of the LC3-labelled 191 
structures.  Although LC3 is the best-established marker to identify autophagosomes, it can 192 
also be associated with single membranes on phagosomes within macrophages and other 193 
phagocytic cell types where it functions in a process called LC3-associated phagocytosis 194 
(LAP) (Sanjuan et al., 2009).  In this instance, following receptor-mediated phagocytosis, LC3 195 
is recruited to the single-membrane phagosomes using the same conjugation machinery as is 196 
involved with macroautophagy.  Therefore, within immune cells, careful interpretation of LC3 197 
puncta is required as it may not only detect autophagosomes, but also LC3-labelled 198 
phagosomes and correlative light and electron microscopy may be critical in differentiating 199 
these processes. 200 
Although these transgenic reporters are powerful tools for studying autophagic processes in 201 
vivo or in primary cultures, there are important caveats to consider.  GFP-LC3 was initially 202 
described to localize exclusively on autophagic membranes. However GFP-LC3 protein can 203 
aggregate in an autophagy-independent manner without being conjugated to 204 
phosphatidylethanolamine leading to misinterpretation of the results, especially during 205 
transient expression of the transgene (Kuma et al., 2007).  For example, GFP-LC3 can be 206 
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seen to localise with intracellular protein aggregates like huntingtin inclusions in autophagy-207 
null cell lines suggesting that GFP-LC3 puncta do not always represent autophagic structures 208 
and therefore LC3 fluorescent localization should be carefully interpreted. Tanida and 209 
colleagues proposed the use of mutant fluorescent LC3 (the human mutation LC3DG) which 210 
cannot be lipidated as negative control (Tanida et al., 2008) and as described below, 211 
transgenic reporters using this control have now been developed (Kaizuka et al., 2016). 212 
Since fluorescently tagged-LC3 labels the surface of all autophagic structures, from the 213 
formation of the phagophore to the autolysosome, no conclusions can be made about 214 
autophagy flux or dynamics by simply measuring the number of puncta. An increase in GFP-215 
LC3 puncta may occur as a result of an increase autophagosome formation but also could be 216 
the consequence of an impairment of autolysosome formation (Klionsky et al., 2016). In cell 217 
culture, the inhibition of vacuolar acidification and consequent inhibition of lysosomal activity 218 
by bafilomycin A1 (Baf) treatment is commonly employed as a tool to investigate changes in 219 
autophagic flux (Rubinsztein et al., 2009). Such treatment prevents the downstream clearance 220 
of autophagosomes and allows a comparison of number of puncta in the presence or absence 221 
of lysosomal degradation (Klionsky et al., 2016). In vivo, chloroquine or ammonium chloride 222 
treatments may be employed to reduce vacuolar acidification, although these treatments are 223 
likely to be toxic at saturating concentrations and therefore, at best, can only be considered to 224 
be a partial lysosomal block. Such an approach has been used to measure cardiac autophagic 225 
flux in vivo in mCherry-LC3 transgenic mice (Iwai-Kanai et al., 2008). A clearer differentiation 226 
between GFP-LC3 associated with autophagosomes or with acidic lysosomes can be 227 
achieved by labelling acidic structures with LysoTracker (He et al., 2009; Sasaki et al., 2014) 228 
or with the use of additional transgenic lysosome markers such as mCherry-Lamp1 (Sasaki et 229 
al., 2017). If the co-localization of acidic structures with fluorescent LC3 puncta increases with 230 
respect to the total number of labelled structures, this may be indicative of an induction in 231 
autophagy. However, this may also occur if there is defective lysosomal function causing 232 
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delayed LC3 degradation, for example as observed when components of the chaperonin 233 
complex are depleted (Pavel et al., 2016). 234 
A further important consideration is the degradation of GFP-LC3, which can generate free 235 
GFP fragments that may accumulate depending on the acidity of the lysosomes and 236 
degradative capacity of lysosomal compartments (Ni et al., 2011). In cell culture, LC3 was 237 
found to be degraded faster than GFP from GFP-LC3 since GFP degradation requires high 238 
lysosomal acidification. Starvation, rapamycin or incomplete suppression of autophagy by low 239 
doses of inhibitors of lysosomal acidification such as chloroquine (CQ) or Baf also led to higher 240 
levels of free GFP fragments from GFP-LC3 in several mammalian cell lines expressing GFP-241 
LC3 (Hosokawa et al., 2006) and similarly in the liver of GFP-LC3 transgenic mice following 242 
CQ treatment (Ni et al., 2011). However, it is important to note that this phenomenon and its 243 
utility varies in different mammalian cell types and cell lines and this method has not been 244 
widely used in mammalian systems. 245 
 246 
Dual fluorophore probes 247 
Since the GFP fluorescent signal is quenched in the acidic environment of autolysosomes, 248 
this limits the utility of this reporter for tracking vesicles during the autophagic process. To 249 
overcome these limitations, a tandem fluorescent tagged-LC3 was developed and initially 250 
characterised in vitro (Kimura et al., 2007). The fluorescent proteins GFP and mRFP have 251 
different properties under acidic conditions. Kimura and collaborators showed that using a 252 
tandem-tagged mRFP-GFP-LC3, GFP fluorescence (pKa 5.9) is quenched in the acidic 253 
environment of the lysosomes, whereas the red fluorescence from the mRFP tag (pKa 4.5) is 254 
maintained due to its different sensitivity to pH. As a consequence, GFP channels and mRFP 255 
channels of the same labelled cells showed different distribution patterns of puncta. The 256 
development of the tandem fluorescent mRFP-GFP-LC3 has been widely used in vitro to study 257 
the mechanisms regulating the maturation of autophagosomes and the fusion to lysosomes 258 
11 
 
 
in the degradative process. Due to this pH-dependent quenching of the GFP-LC3 259 
fluorescence, only mRFP-LC3 can be detected in autolysosomes (i.e. these appear red only), 260 
whereas autophagosomes can be visualised by both fluorophores (i.e. these appear orange) 261 
(see Fig.3).  262 
The first in vivo mouse model expressing mRFP‑GFP‑LC3 was generated by Li and 263 
colleagues in 2014 (Li et al., 2014). Expression of the LC3 tandem reporter was ubiquitous, 264 
which allowed a better understanding of the dynamics of autophagy in vivo under stress 265 
conditions, such as starvation and disease. In these RFP-EGFP-LC3 mice, autophagic 266 
vacuoles were visualised as RFP- and EGFP-positive puncta, similar to in vitro observations 267 
in cells expressing the same construct. The model was first used to evaluate the role of 268 
autophagy in ischemia-reperfusion injury in the kidney using primary cell culture. In addition, 269 
primary cortical neurons from an independently generated mouse line have been used to 270 
investigate the interplay between chaperone proteins and autophagy (Pavel et al., 2016). 271 
Tandem construct mCherry- or RFP-GFP-LC3 have also been used in zebrafish. Transient 272 
expression of RFP-GFP-LC3 in zebrafish was used to investigate the autophagy pathway in 273 
the clearance of mycobacterium infection. Treatment with carbamazepine was shown to 274 
improve the clearance of mycobacterial infection in vivo and increase autophagic flux in larvae 275 
zebrafish (Schiebler et al., 2015). Stable transgenic zebrafish expressing mCherry-GFP-276 
map1lc3b have also been used to evaluate the autophagic and late endosomal trafficking 277 
pathways in the cone photoreceptors of synJ1-deficient zebrafish (Allwardt et al., 2001; 278 
George et al., 2016; Van Epps et al., 2001). Live time-lapse confocal microscopy revealed an 279 
increase in the formation of autophagosome precursors and a defect in autophagosome 280 
maturation in vivo in synJ1-deficient zebrafish, resulting in the accumulation of 281 
autophagosomes. Modulation of the PI(4,5)P2 regulator, Arf6, by expressing a constitutively 282 
active mutant of Arf6, rescued the defects seen in cones of synJ1-deficient fish. These results 283 
suggest that Arf6a modulates positively the levels of PI(4,5)P2, substrate for SynJ1, and hence 284 
that both Arf6 and SynJ1 play a role in the same pathway to regulate autophagy in cone 285 
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photoreceptors (George et al., 2016). These studies highlight the potential of the zebrafish 286 
model to characterize aspects of vesicle transport in vivo.  287 
However, as with the analysis of GFP-tagged LC3, there are additional factors to be 288 
considered when using this tandem red-green fluorescent LC3 fusion protein.  Firstly, the red 289 
and green fluorescence from unconjugated LC3 exists in the cytosol of all cells.  When 290 
autophagic flux is low, this background is higher.  As the LC3 becomes conjugated and more 291 
puncta appear, the background fluorescence decreases (see Fig. 3).  Identifying puncta 292 
against this fluorescent background is challenging and care must be taken in quantifying the 293 
number of autophagosomes in conditions where the background fluorescence changes. 294 
Secondly, due to the pH-sensitivity of the GFP signal, reduction in the green signal may 295 
depend not only on the enzymatic degradation of GFP itself but also the speed at which the 296 
lysosomal content acidifies (Mizushima et al., 2010). Thus, what one is formally assessing are 297 
the numbers of unacidified versus acidified LC3-containing vesicles, which may not always be 298 
the same as the numbers of autophagosomes prior to lysosome fusion versus autolysosomes.  299 
The development of new generation of fluorescent probes may help with some of these 300 
difficulties. A new dual fluorescence probe was recently generated by the Mizushima group 301 
comprising GFP-LC3-RFP-LC3DG (Kaizuka et al., 2016).  The expression of the construct 302 
results a protein that is cleaved by Atg4 proteases resulting in the equimolar amounts of two 303 
separate fluorescently tagged proteins; GFP-LC3 and RFP-LC3DG. RFP-LC3DG is a mutated 304 
form of LC3, which cannot be conjugated (see Fig. 4). It is therefore unable to attach to 305 
autophagic membranes, remaining in the cytosol and hence can be used as an internal 306 
control. However, GFP-LC3 can be lipidated and attaches to the autophagosome membrane.  307 
GFP-LC3 on the inner autophagosome membrane is degraded by autophagy whereas on the 308 
outer membrane it is deconjugated by Atg4 and returns to the cytosol. The ratio of GFP/RFP 309 
can therefore be used as a measurement of autophagic flux as it assesses LC3 degradation 310 
via a conjugation-dependent route (i.e. autophagy). However, as only a small proportion of the 311 
protein is degraded the windows of detection are limited. 312 
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Mice and zebrafish expressing GFP-LC3-RFPLC3DG were developed to evaluate autophagic 313 
flux in different tissues and validated to confirm that the reporter responds appropriately to 314 
drug induced autophagy upregulation (Kaizuka et al., 2016). Although the transgene was 315 
detected in several tissues by western blotting in mice, only skeletal muscle showed sufficient 316 
levels of expression for fluorescence analysis. Post-mortem analysis of muscle sections was 317 
used to evaluate fed versus fasted conditions. Interestingly, their findings suggest that slow 318 
and fast twitch muscle fibres have different levels of basal autophagy (Kaizuka et al., 2016). 319 
The use of other fluorescent tandem reporters with different pH-sensitivities, such as mWasabi 320 
(pKa at 6.5 vs.  pKa 5.9 of GFP) leads to a faster loss of fluorescence in the autolysosomes 321 
(Zhou et al., 2012) and may be a better tool for tracking autophagy flux in vivo. Both mTagRFP 322 
and mWasabi-LC3 are much brighter than mRFP/mCherry and EGFP fluorescence. mWasabi 323 
is also more acid-sensitive than EGFP and hence more easily quenched in the acidic 324 
environment of autolysosomes (Chudakov et al., 2010). In addition, the pKa of mTagRFP (4.0) 325 
is lower than that of mRFP (4.5) suggesting that mTagRFP is more stable than mRFP in acidic 326 
conditions (Shaner et al., 2004). These characteristics make discrimination of autolysosomes 327 
and autophagosomes more accurate than other fluorophores and were used to investigate the 328 
dose-dependent effect of autophagy inducers in the autophagic flux in cells (Zhou et al., 2012). 329 
However, no in vivo models have been created using this construct. Similarly Rosella, a 330 
tandem reporter of the fast maturing red fluorescent protein dsRed.T3 with GFP, has been 331 
used being successfully used to track labelled cytosolic proteins, mitochondria or the nucleus 332 
to the autophagic vacuole in yeast (Mijaljica et al., 2011; Rosado et al., 2008). Rosella-LC3 333 
and Mito-Rosella biosensors have been developed and characterised in HeLa cells (Sargsyan 334 
et al., 2015). These authors reported that transgenic mouse models for Rosella-LC3 and Mito-335 
Rosella biosensors were being developed to measure mitophagy and autophagic flux in 336 
different tissues in vivo, although no further data have been published to date. 337 
 338 
pH-sensitive probes 339 
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In contrast to the use of dual fluorophores to label LC3, new approaches have been developed 340 
in recent years which allow one to measure autophagic flux using a single fluorophore. 341 
dKeima, a coral-derived fluorophore, has a bimodal excitation spectrum (438 and 550 nm) 342 
with an emission spectrum peak at 620 nm (Kogure et al., 2006).  The different excitation 343 
wavelengths correspond to the neutral and ionized states of the chromophore with the neutral 344 
state (438 nm excitation) predominant at neutral/high pH and the ionized state (550 nm 345 
excitation) more abundant at low pH. Therefore dual excitation ratiometric imaging (438/550 346 
nm) can be used to determine the environmental pH (Katayama et al., 2011). In cell culture 347 
experiments, dKeima was demonstrated to be delivered to lysosomes via the autophagic 348 
pathway and was observed to accumulate inside the lysosomal compartments because it is 349 
resistant to degradation by lysosomal proteases (Katayama et al., 2011). Hence ratiometric 350 
imaging over time can be used to monitor the maturation of autolysosomes and therefore 351 
autophagic flux. Furthermore, since the emission spectrum of dKeima peaks at 620 nm, this 352 
probe can be simultaneously imaged with green fluorophores (e.g. EGFP-LC3) without cross-353 
detection or excitation (Katayama et al., 2011).  354 
In addition, Keima can be targeted to either proteins or organelles. For example, Keima 355 
targeted to mitochondria (Mito-Keima) has been used to evaluate mitochondrial autophagy 356 
(mitophagy) in cell culture (Katayama et al., 2011). Mito-Keima has also been used in mice 357 
via intravenous injection of adeno-associated virus (AVV9) harbouring either Mito-Keima or 358 
Lamp1-YFP (yellow fluorescent protein) to evaluate mitophagy in cardiomyocytes of the adult 359 
heart (Shirakabe et al., 2016). Confocal imaging of thin slices of the heart showed Lamp1-360 
YFP dots colocalizing with acidic Mito-Keima (561 nm) after 48-hour starvation of the animals, 361 
suggesting that the lysosomal degradation of mitochondria is stimulated after fasting. 362 
Labelling autophagic substrates 363 
An alternative approach is not to measure autophagosomes per se but to measure the 364 
clearance of autophagic substrates.  Tau is a microtubule associated protein which is known 365 
to be an autophagy substrate (Lee et al., 2013).  Zebrafish models have been developed 366 
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expressing a transgenic construct comprising human tau tagged with the photoconvertible 367 
fluorescent protein, Dendra.  The fluorescently tagged tau protein is visible as green 368 
fluorescence but this can be converted to a red fluorescent protein by exposure to 405 nm 369 
wavelength light.  This conversion labels a steady-state pool of tau protein allowing clearance 370 
kinetics to be measured without being confounded by new protein synthesis (since newly 371 
formed protein will be green).  This method has been used to assess both genetic modifiers 372 
of tau clearance (Moreau et al., 2014) and also to assess clearance of wildtype and mutant 373 
forms of tau in response to autophagy stimulus (Lopez et al., 2017).  Such studies have 374 
provided the first observations of substrate clearance in neurons in vivo (see Fig. 5). This 375 
approach has also been used to study the clearance of mutant huntingtin in cell culture 376 
(Tsvetkov et al., 2013). Although clearance of substrates is likely affected by both the 377 
proteasome and autophagy, the use of proteasome blocking agents (e.g. MG132) and 378 
lysosomal acidification inhibitors (e.g. Baf, CQ or ammonium chloride) allows discrimination 379 
between the two clearance pathways and an assessment of the relative contribution of each. 380 
 381 
Future directions/conclusions 382 
To date, much of our understanding of autophagosome formation, trafficking and degradation 383 
have come from work in cell lines or in primary cell culture.  The elegant work of the Holzbaur 384 
group in studying trafficking in primary neurons has revealed important aspects of 385 
autophagosome trafficking and biogenesis (Fu et al., 2014; Maday and Holzbaur, 2014; Maday 386 
and Holzbaur, 2016).  Given the tools described here, and the advances imaging techniques, 387 
it is likely that we now have the ability to investigate many of these processes in vivo.  Indeed, 388 
such approaches have been applied to the in vivo trafficking of mitochondria (Drerup et al., 389 
2017; Dukes et al., 2016; Plucinska et al., 2012). Caveats remain about the fidelity of 390 
transgenicly labelled proteins, since these protein-tags are expressed in addition to the 391 
endogenous protein, typically at higher levels than the endogenous protein and are not 392 
controlled by the endogenous promoter. However, chromobody labelling may be one 393 
16 
 
 
approach that can be used to overcome this.  These are small antigen recognising elements 394 
(nanobodies) fused to fluorescent reporters and have been used to label actin cytoskeleton 395 
and cell cycle associated proteins in zebrafish (Panza et al., 2015). In addition, recent 396 
advances in CRISPR- and TALEN- mediated knock-in methodologies (Albadri et al., 2017; 397 
Schmid-Burgk et al., 2016) suggest that in future it may be possible to specifically add tags to 398 
endogenous proteins. Therefore, although we have not yet exploited the full power of the 399 
transgenic, genomic editing and imaging technologies, the tools are now available to allow us 400 
to better investigate the process of autophagy in health and disease within living tissues. Since 401 
autophagy impacts on a diverse range of pathological conditions such as neurodegeneration, 402 
infection and cancer, the ability to visualise how autophagic flux is affected in vivo in such 403 
disease states will provide valuable information on which steps of the pathway can be 404 
manipulated for therapeutic benefit. 405 
 406 
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Figure Legends 615 
Figure One: Autophagosome formation. (A) Schematic of autophagosome formation and 616 
degradation: Within the cytoplasm, double-membraned, sac-like structures called a 617 
phagophores are the first morphologically recognizable autophagic precursors and can be 618 
distinguished within cells by the proteins that associate with their membranes.  A complex 619 
comprising ATG12–ATG5–ATG16L1 proteins enables the conjugation of LC3-II to the 620 
membranes. The edges of the phagophore elongate and eventually fuse while engulfing a 621 
portion of the cytoplasm. As the phagophore enlarges and approaches closure, the ATG5–622 
ATG12–ATG16L1 complex dissociates from the outer membrane, whereas LC3-II remains 623 
associated.  The resulting structure is a spherical double-membrane organelle, called the 624 
autophagosome. Following closure, autophagosomes are trafficked by dynein motors along 625 
microtubules to the perinuclear region where they fuse with the lysosomes and their contents 626 
are degraded. (B) Lipidation of LC3-II: During autophagosome formation, LC3 (and other 627 
ATG8 ubiquitin-like family proteins) are conjugated to the lipid phosphatidylethanolamine (PE) 628 
in autophagosome membranes. This lipidation requires a protease and two ubiquitin-like 629 
conjugation systems (explained in detail in Ichimura et al., 2000; Mizushima et al., 1998). 630 
ATG4 is a cysteine protease which cleaves the C-terminus of LC3 exposing a glycine residue.  631 
This first cleaved form of LC3 is called LC3-I. A further reaction then occurs involving a 632 
complex of ATG12-5 and ATG16L1, which together act as an E3-like ligase. This determines 633 
the site of LC3 lipidation and assists the transfer of LC3-I to PE in membranes to form LC3-II. 634 
ATG8/LC3 proteins may assist in the expansion and closure of autophagosomal membranes, 635 
in autophagosome-lysosome fusion and inner autophagosomal membrane degradation.  636 
 637 
Figure Two: Schematic diagram of conventional methods to measure rates of 638 
autophagy. (A&B) Western blots for LC3-II: Measuring LC3 lipidation by western blotting is 639 
one of the best-established methods for measuring autophagic flux.  However, care must be 640 
taken in interpreting increases in LC3 levels as this may occur as a result of an increase in 641 
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autophagosome formation (upregulation) or a blockage in clearance. To discriminate between 642 
these two scenarios, assays should be performed in basal conditions and in the presence of 643 
an agent that prevents lysosomal degradation such as bafilomycin A1 (Baf) or ammonium 644 
chloride (NH4Cl). (A) When autophagy is induced, LC3-II levels increase as more 645 
autophagosomes are formed.  In the presence of a lysosomal blocker, LC3-II levels increase 646 
further because increased autophagosome formation still occurs, but autophagosomes cannot 647 
be cleared and therefore build up within the cell. (B) In some conditions when autophagy is 648 
blocked (for example, if fusion with the lysosome is prevented), LC3-II levels can also increase 649 
since autophagosomes may form but are not degraded.  In this scenario, when LC3-II levels 650 
are measured in the presence of Baf or NH4Cl, LC3-II levels are unchanged.  The difference 651 
in patterns between (A) and (B) can be used to discriminate between autophagy induction and 652 
blockage. (C) When LC3-labelled vesicles (puncta) are measured within cells with a single 653 
fluorophore (e.g. cells expressing GFP-tagged LC3 or immunofluorescence labelling of the 654 
endogenous protein), an increase in puncta can be observed both in autophagy inducing and 655 
autophagy blockage conditions. N.B. Commercially available antibodies with cross-reactivity 656 
to zebrafish LC3 are widely available from suppliers such as from Novus Biologicals (used in 657 
He et al., 2009; Moreau et al., 2014; Lopez et al., 2017) and Cell Signaling Technology (used 658 
in Sasaki et al., 2014). 659 
 660 
Figure Three: Schematic diagram of the tandem mRFP-EGFP-LC3 expression to monitor 661 
autophagic flux. (A) Representation of the reporter construct mRFP-EGFP-LC3 and the 662 
behaviour of its transcript upon different pH conditions. Under neutral pH conditions, both 663 
EGFP and RFP fluorescence is observed.  Under acidic pH conditions, EGFP fluorescence is 664 
quenched and only red fluorescence is observed. (B) mRFP-EGFP-LC3 labelling during 665 
autophagosome biogenesis, maturation and degradation. Unlipidated mRFP-EGFP-LC3 666 
remains in the cytoplasm (light yellow) whereas lipidated mRFP-EGFP-LC3 is recruited to both 667 
inner and outer membranes of phagophores and double membrane autophagosomes. During 668 
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these steps of autophagosome formation, the fluorescent signal of both fluorophores, mRFP 669 
and EGFP, is visible and vesicles appear as yellow puncta. Autophagosomes eventually fuse 670 
with lysosomes to form autolysosomes. Under these acidic conditions, the contents within the 671 
inner membrane are eventually degraded. The green fluorescent signal from EGFP is 672 
quenched in the acidic lysosomal conditions whereas the mRFP signal remains, resulting in 673 
red autolysosomes. (C) Representative images of a cell expressing mRFP-EGFP-LC3 with 674 
different levels of autophagy. The combination of green and red fluorescent signals from 675 
unlipidated mRFP-EGFP-LC3 results in a yellow background in the cytoplasm of the cells. The 676 
intensity of this yellow may change dependent upon changes in the autophagy flux. Under low 677 
autophagy conditions, most of mRFP-EGFP-LC3 remains unlipidated resulting in a yellow 678 
background and only a few yellow or red vesicles (autophagosomes and autolysosomes) are 679 
seen. After autophagy induction, many new autophagosomes form and are labelled with 680 
lipidated LC3. These rapidly fuse with lysosomes. This can be observed as an increase in the 681 
number of total vesicles and the ratio of red:yellow vesicles as well as reduced yellow 682 
background. When autophagic flux is blocked, autophagosome formation may still occur. In 683 
this scenario, autophagosomes and autolysosomes accumulate but cannot be degraded and 684 
can be observed as yellow puncta. The continuous lipidation of mRFP-EGFP-LC3 as new 685 
autophagosomes form reduces the yellow background of the cytoplasm. 686 
Figure Four: Schematic diagram of the GFP-LC3-RFP-LC3DG reporter to measure 687 
autophagic flux. (A) Schematic diagram of the GFP-LC3-RFP-LC3DG reporter construct. 688 
The GFP-LC3-RFP-LC3DG protein is cleaved by ATG4 resulting in the release of GFP-LC3 689 
and RFP-LC3DG in equimolar amounts. (B) GFP-LC3 becomes lipidated and binds to 690 
autophagosomes and autophagosome precursors and can be visualised as green vesicles 691 
(puncta), whereas unlipidated RFP-LC3DG remains in the cytoplasm. The GFP signal is 692 
quenched when autophagosomes fuse to lysosomes to form autolysosomes. The green signal 693 
can therefore be used as a marker for phagophores and autophagosomes, but autolysosomes 694 
are not labelled. (C) Representative images of a cell expressing GFP-LC3-RFP-LC3DG with 695 
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different levels of autophagy. The unlipidated RFP-LC3DG is released as an internal control 696 
at the same rate and amount as GFP-LC3 and always remains cytosolic. Levels of red signal 697 
are independent of autophagy degradation and remain unchanged upon autophagy 698 
perturbation. GFP-LC3 however can be found unlipidated free in the cytoplasm or lipidated 699 
hence bound to autophagic membranes and therefore susceptible to autophagy degradation. 700 
Under high levels of autophagic flux, GFP-LC3 becomes lipidated and degraded, and thereby 701 
the level of green signal is reduced. When autophagy is blocked, the accumulation of 702 
unlipidated GFP-LC3 and the lack of degradation of the lipidated form results in an increase 703 
in the GFP signal. The ratio of the GFP:RFP (i.e. the green signal from GFP-LC3 and the 704 
unchanged mRFP-LC3DG) is then used to measure the rate of autophagic flux. 705 
 706 
Figure Five: Measuring autophagy substrate clearance in vivo. (A) Zebrafish were 707 
generated which express the fluorescent, photoconvertible protein Dendra tagged to human 708 
tau, a known autophagy substrate.  The green fluorescent Dendra protein can be 709 
photoconverted to a red fluorescent protein by exposure to 405 nm light.  (B) Mosaic 710 
expression of the transgene allows individual neurons in the spinal cord to be identified and 711 
selected for photoconversion.  Images of the same neurons were taken before and 712 
immediately after photoconversion and then at 12-hour intervals.  The amount of red 713 
fluorescent signal was quantified at each time point and used to calculate the clearance of tau 714 
protein. (C) Schematic diagram of the clearance kinetics of tau following in response to 715 
manipulation of autophagic flux.  Treatment with autophagy inducers (green) accelerates the 716 
clearance of tau protein whereas treatment with autophagy blockers (red) slows the clearance 717 
kinetics. 718 
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 720 
Table One: Comparison of zebrafish and human orthologues of ATG8  721 
Zebrafish 
gene 
Description Ensembl ID Human 
orthologue 
Percentage 
identity to human 
orthologue 
Map1lc3a microtubule-
associated 
protein 1 light 
chain 3 alpha  
ENSDARG00000033609 MAP1LC3A 85.95% 
Map1lc3b microtubule-
associated 
protein 1 light 
chain 3 beta  
ENSDARG00000101127 MAP1LC3B2 92.62% 
Map1lc3c microtubule-
associated 
protein 1 light 
chain 3 gamma 
ENSDARG00000100528 MAP1LC3C 65.47% 
Map1lc3cl microtubule-
associated 
protein 1 light 
chain 3 gamma, 
like 
ENSDARG00000075727 No human 
orthologue 
(58.73% identity 
to zebrafish 
map1lc3c) 
gabarapa GABA(A) 
receptor-
associated 
protein a  
ENSDARG00000035557 GABARAP 93.44% 
gabarapb GABA(A) 
receptor-
associated 
protein b  
ENSDARG00000052082 GABARAP 75.66% 
Unnamed Unnamed ENSDARG00000040971 GABARAPL1 58.97% 
gabarapl2 GABA(A) 
receptor-
associated 
protein like 2  
ENSDARG00000027200 GABARAPL2 96.58% 
 722 
 723 





